SCHEMBL13594

SCHEMBL13594

Brc1ccc2c(c1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL8701960 0.97 PNMT (0.56)
SCHEMBL1468326 0.89 PNMT (0.54)
SCHEMBL749569 0.89 PNMT (0.54)
SCHEMBL18457177 0.88 PNMT (0.48)
SCHEMBL10182282 0.88 TDP1 (0.48)
SCHEMBL18746500 0.87 PNMT (0.52)
SCHEMBL21447111 0.87 PNMT (0.52)
SCHEMBL22910024 0.87 PNMT (0.52)
SCHEMBL6192350 0.87 PNMT (0.52)
Ammonia Solution, Strong SCHEMBL4733194 0.87 PNMT (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 385 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021078217-A1 TETRACENE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 中国科学院化学研究所 2021-04-29 WO claimed
CN-112694388-A Naphthacene derivative and preparation method and application thereof 中国科学院化学研究所 2021-04-23 CN claimed
US-12612360-B2 Substituted 6,7-dihydro-5H-benzo[7]annulene compounds and their derivatives, processes for their preparation and therapeutic uses thereof SANOFI (FR) 2026-04-28 US disclosed
EP-3515892-B1 COMPOUNDS AND METHODS FOR IDO AND TDO MODULATION, AND INDICATIONS THEREFOR PLEXXIKON INC (US) 2026-04-15 EP disclosed
EP-4667458-A1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER, COMPRISING SOS1 INHIBITOR AND ANTICANCER DRUG Kanaph Therapeutics Inc. (KR) 2025-12-24 EP disclosed
EP-4642784-A1 HETEROCYCLIC AND HETEROARYL COMPOUNDS AS INHIBITORS OF NLRP3 PTC Therapeutics, Inc. (US) 2025-11-05 EP disclosed
US-20250326765-A1 PDE4B INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2025-10-23 US disclosed
US-20250263426-A1 PDE4B INHIBITOR AND USE THEREOF XIZANG HAISCO PHARMACEUTICAL CO., LTD. (CN) 2025-08-21 US disclosed
EP-4534540-A1 PDE4B INHIBITOR AND USE THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2025-04-09 EP disclosed
WO-2025026270-A1 BENZO NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE REGULATOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2025-02-06 WO disclosed
US-20240400518-A1 SOS1 INHIBITOR AND USE THEREOF CYRUS THERAPEUTICS INC. (KR) 2024-12-05 US disclosed
US-5227536-A PROCESS FOR PREPARING HYDROXYBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-07-13 US disclosed
WO-1993006072-A1 PROCESS FOR PREPARING HYDROXYBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-04-01 WO disclosed
WO-1993006083-A1 PROCESS FOR PREPARING AMINOBENZOCYCLOBUTENES THE DOW CHEMICAL COMPANY (US) 1993-04-01 WO disclosed
US-5196103-A Dielectric polycyclobutarene layer, adhesion, metal carbide interface, sputtering THE DOW CHEMICAL COMPANY (US) 1993-03-23 US disclosed
US-5136069-A Reacting with halogenated organic compound in presence of palladium complex catalyst and inorganic hydrogen halide acceptor THE DOW CHEMICAL COMPANY (US) 1992-08-04 US disclosed
EP-0323536-A1 Arylcyclobutene/dienophile copolymers THE DOW CHEMICAL COMPANY (US) 1989-07-12 EP disclosed
US-4783514-A Polymeric monoarylcyclobutane compositions THE DOW CHEMICAL COMPANY (US) 1988-11-08 US disclosed
US-4730030-A Arylcyclobutane/dienophile copolymer THE DOW CHEMICAL COMPANY (US) 1988-03-08 US disclosed
US-4724260-A Unsaturated alkyl monoarylcyclobutane monomers THE DOW CHEMICAL COMPANY (US) 1988-02-09 US disclosed